Drug intelligence / Profile preview

omega-3-acid ethyl ester

Development stage
Approved
Lead developer
Reliant
Modality
Small Molecules
Administration
Oral
01

Overview

Omega-3-acid ethyl ester is a prescription medication composed primarily of the ethyl esters of two long-chain omega-3 polyunsaturated fatty acids found in fish oil—eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). It is used as an adjunct to diet to reduce very high triglyceride levels (≥500 mg/dL) in adults. The drug works by reducing hepatic production of triglycerides, increasing fatty acid metabolism through enhanced beta-oxidation, inhibiting the release of free fatty acids by competing for enzymes involved in triglyceride synthesis, increasing clearance via lipoprotein lipase activity, and decreasing production of very low-density lipoprotein cholesterol (VLDL-C). The exact mechanism is not fully understood. Omega-3-acid ethyl ester may also modestly increase HDL ("good" cholesterol), but can raise LDL ("bad" cholesterol) in some patients. It is taken orally as a liquid-filled capsule[1][4][5][6].

Brand names
LovazaOmtryg
Other names
omega-3-acid ethyl estersomega3-acid ethyl estersomega 3-acid ethyl estersomega-3 fatty acid ethyl estersomega3 fatty acid ethyl estersomega 3 fatty acid ethyl estersEPA/DHA ethyl esters
02

Targets

DGAT1 (Diacylglycerol O-acyltransferase 1)LPL (Lipoprotein lipase)SREBP-1 / SREBF1 (SREBP-1)

Beyond the preview

Go deeper on omega-3-acid ethyl ester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omega-3-acid ethyl ester.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call